Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dr. Reddy's Laboratories Ltd (RDY)

Dr. Reddy's Laboratories Ltd (RDY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,531,974
  • Shares Outstanding, K 165,720
  • Annual Sales, $ 2,225 M
  • Annual Income, $ 272,000 K
  • 60-Month Beta 0.17
  • Price/Sales 3.41
  • Price/Cash Flow 16.99
  • Price/Book 3.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.38
  • Growth Rate Est. (year over year) +262,794.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.23 +12.98%
on 01/16/20
46.19 -1.60%
on 02/13/20
+3.56 (+8.50%)
since 01/14/20
3-Month
38.21 +18.95%
on 11/15/19
46.19 -1.60%
on 02/13/20
+7.17 (+18.73%)
since 11/14/19
52-Week
34.67 +31.09%
on 08/28/19
46.19 -1.60%
on 02/13/20
+7.74 (+20.53%)
since 02/14/19

Most Recent Stories

More News
Dr. Reddy's Laboratories to Acquire Select Business Divisions of Wockhardt in India

Dr. Reddy's Laboratories Ltd. ("Dr. Reddy's") (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that it has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of...

RDY : 45.45 (-0.87%)
Dr. Reddy's Laboratories Announces the Launch of Trientine Hydrochloride Capsules USP, 250 mg, in the U.S. Market

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as "Dr. Reddy's") today announced the launch of Trientine Hydrochloride Capsules USP,...

RDY : 45.45 (-0.87%)
Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into an amendment of its collaboration,...

RDY : 45.45 (-0.87%)
CRIS : 1.46 (unch)
Dr. Reddy's Selects Kinaxis to Transform Supply Chain and Business Operations

India-based multinational pharmaceuticals company to gain end-to-end visibility, better collaboration and decision-making

RDY : 45.45 (-0.87%)
KXS.TO : 116.30 (-0.01%)
Dr. Reddy's (RDY) Q3 Earnings and Revenues Increase Y/Y

Dr. Reddy's (RDY) earnings (excluding impairment charge) increase year over year in the third quarter of fiscal 2020.

SNY : 49.93 (-0.14%)
LLY : 141.12 (-0.48%)
BMY : 66.38 (+0.45%)
RDY : 45.45 (-0.87%)
Dr. Reddy's Q3 & 9M FY20 Financial Results

Dr. Reddy's Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the quarter ended December 31, 2019 under International Financial Reporting...

RDY : 45.45 (-0.87%)
New Strong Sell Stocks for January 10th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

CNI : 93.93 (+0.05%)
HTLD : 19.84 (-2.07%)
ARCH : 56.01 (-1.60%)
RDY : 45.45 (-0.87%)
ARD : 20.41 (+1.39%)
Dr. Reddy's to Release Q3 FY 20 results on January 27, 2020 Earnings Call Slated for January 27, 2020 @ 6:30 PM IST / 8:00 AM EST

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the third quarter ended December 31, 2019 on Monday, January 27, 2020 after the Board Meeting.

RDY : 45.45 (-0.87%)
Dr. Reddy's Laboratories Announces the Launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. Market

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as "Dr. Reddy's") today announced the launch of Sodium Nitroprusside Injection, 50...

RDY : 45.45 (-0.87%)
Dr. Reddy's Laboratories Announces the Launch of Deferasirox Tablets for Oral Suspension, in the U.S. Market

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as "Dr. Reddy's") today announced the launch of Deferasirox Tablets for Oral Suspension,...

RDY : 45.45 (-0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade RDY with:

Business Summary

Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally,...

See More

Key Turning Points

2nd Resistance Point 46.32
1st Resistance Point 45.88
Last Price 45.45
1st Support Level 45.14
2nd Support Level 44.84

See More

52-Week High 46.19
Last Price 45.45
Fibonacci 61.8% 41.79
Fibonacci 50% 40.43
Fibonacci 38.2% 39.07
52-Week Low 34.67

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar